CN103172749B - 一种非洲猪瘟蛋白工程疫苗的制备 - Google Patents
一种非洲猪瘟蛋白工程疫苗的制备 Download PDFInfo
- Publication number
- CN103172749B CN103172749B CN201310038763.0A CN201310038763A CN103172749B CN 103172749 B CN103172749 B CN 103172749B CN 201310038763 A CN201310038763 A CN 201310038763A CN 103172749 B CN103172749 B CN 103172749B
- Authority
- CN
- China
- Prior art keywords
- cct
- vaccine
- swine fever
- african swine
- protein engineering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 76
- 208000007407 African swine fever Diseases 0.000 title claims abstract description 47
- 108090000623 proteins and genes Proteins 0.000 title abstract description 66
- 102000004169 proteins and genes Human genes 0.000 title abstract description 56
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 150000007523 nucleic acids Chemical class 0.000 claims description 7
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 239000003937 drug carrier Substances 0.000 claims description 3
- 108020001507 fusion proteins Proteins 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 241000701386 African swine fever virus Species 0.000 abstract description 36
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 17
- 241001465754 Metazoa Species 0.000 abstract description 10
- 238000000746 purification Methods 0.000 abstract description 6
- 210000001744 T-lymphocyte Anatomy 0.000 abstract description 5
- 239000012528 membrane Substances 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 241001248531 Euchloe <genus> Species 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- 101710142252 Protein P54 Proteins 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 230000028996 humoral immune response Effects 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 49
- 210000004027 cell Anatomy 0.000 description 20
- 102100021409 Probable ATP-dependent RNA helicase DDX17 Human genes 0.000 description 17
- 101800000958 Reverse transcriptase/ribonuclease H Proteins 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- 241000282326 Felis catus Species 0.000 description 14
- 241000282898 Sus scrofa Species 0.000 description 14
- 241000700605 Viruses Species 0.000 description 14
- 229920001184 polypeptide Polymers 0.000 description 14
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 230000036039 immunity Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 239000013612 plasmid Substances 0.000 description 13
- 230000003053 immunization Effects 0.000 description 11
- 238000002649 immunization Methods 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 238000000855 fermentation Methods 0.000 description 10
- 230000004151 fermentation Effects 0.000 description 10
- 101710154606 Hemagglutinin Proteins 0.000 description 9
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 9
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 9
- 101710176177 Protein A56 Proteins 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 239000000185 hemagglutinin Substances 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 8
- 230000001413 cellular effect Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 241000282887 Suidae Species 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 5
- 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000004153 renaturation Methods 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- -1 1 μ l Substances 0.000 description 4
- 102100033458 26S proteasome non-ATPase regulatory subunit 4 Human genes 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 101710172711 Structural protein Proteins 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 229940031567 attenuated vaccine Drugs 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000008105 immune reaction Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000009781 safety test method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 231100000041 toxicology testing Toxicity 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 108010087302 Viral Structural Proteins Proteins 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 210000002955 secretory cell Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 101710125418 Major capsid protein Proteins 0.000 description 2
- 101000933967 Pseudomonas phage KPP25 Major capsid protein Proteins 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 206010058874 Viraemia Diseases 0.000 description 2
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 239000000568 immunological adjuvant Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229940031551 inactivated vaccine Drugs 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 238000009020 BCA Protein Assay Kit Methods 0.000 description 1
- 101100493713 Caenorhabditis elegans bath-45 gene Proteins 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108010041986 DNA Vaccines Proteins 0.000 description 1
- 229940021995 DNA vaccine Drugs 0.000 description 1
- 102100040565 Dynein light chain 1, cytoplasmic Human genes 0.000 description 1
- 101710096197 Dynein light chain 1, cytoplasmic Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241000701377 Iridoviridae Species 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101000957149 Paramecium bursaria Chlorella virus 1 Major capsid protein Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000208966 Polygala Species 0.000 description 1
- 241000700625 Poxviridae Species 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 230000005867 T cell response Effects 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000010530 Virus Neutralization Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 102000013035 dynein heavy chain Human genes 0.000 description 1
- 108060002430 dynein heavy chain Proteins 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000021633 leukocyte mediated immunity Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000009871 tenuigenin Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
组别 | 动物数量 | 体温 | 食欲 | 健康状况 | 死亡数量 |
20120301 | 5 | 正常 | 正常 | 健康状况良好 | 0 |
20120302 | 5 | 正常 | 正常 | 健康状况良好 | 0 |
20120303 | 5 | 正常 | 正常 | 健康状况良好 | 0 |
对照 | 2 | 正常 | 正常 | 健康状况良好 | 0 |
组别 | 动物数量 | 体温 | 食欲 | 健康状况 | 死亡数量 |
20120301 | 2 | 正常 | 正常 | 健康状况良好 | 0 |
20120302 | 2 | 正常 | 正常 | 健康状况良好 | 0 |
20120303 | 2 | 正常 | 正常 | 健康状况良好 | 0 |
对照 | 2 | 正常 | 正常 | 健康状况良好 | 0 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310038763.0A CN103172749B (zh) | 2013-02-01 | 2013-02-01 | 一种非洲猪瘟蛋白工程疫苗的制备 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310038763.0A CN103172749B (zh) | 2013-02-01 | 2013-02-01 | 一种非洲猪瘟蛋白工程疫苗的制备 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103172749A CN103172749A (zh) | 2013-06-26 |
CN103172749B true CN103172749B (zh) | 2014-10-08 |
Family
ID=48632987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310038763.0A Active CN103172749B (zh) | 2013-02-01 | 2013-02-01 | 一种非洲猪瘟蛋白工程疫苗的制备 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103172749B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021210924A1 (ko) * | 2020-04-14 | 2021-10-21 | (주)플럼라인생명과학 | 아프리카돼지열병 백신 조성물 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103952401A (zh) * | 2014-02-28 | 2014-07-30 | 深圳出入境检验检疫局动植物检验检疫技术中心 | 克隆表达优化的非洲猪瘟vp72基因引物序列、基因、核酸疫苗及构建方法 |
GB201410971D0 (en) | 2014-06-19 | 2014-08-06 | Pirbright Inst The | Vaccine |
CN104497136B (zh) * | 2014-12-05 | 2017-10-31 | 深圳出入境检验检疫局动植物检验检疫技术中心 | 非洲猪瘟病毒基因ii型毒株单克隆抗体及制备方法和应用 |
CN106526181A (zh) * | 2016-11-22 | 2017-03-22 | 无锡艾科瑞思产品设计与研究有限公司 | 一种猪瘟病毒的快速检测方法 |
CN108148138B (zh) * | 2017-12-14 | 2020-05-05 | 石河子大学 | 非洲猪瘟病毒多表位融合诊断抗原及其制备方法和用途 |
KR20210092762A (ko) * | 2018-11-15 | 2021-07-26 | 캔사스 스테이트 유니버시티 리서치 파운데이션 | 아프리카 돼지 열병 바이러스에 대한 면역원성 조성물 |
CN111658768A (zh) * | 2019-03-08 | 2020-09-15 | 浙江海隆生物科技有限公司 | 一种非洲猪瘟的多组分亚单位疫苗及其制备方法和应用 |
WO2020251284A1 (ko) * | 2019-06-12 | 2020-12-17 | 연세대학교 원주산학협력단 | 아프리카 돼지 열병 바이러스 유래 p72, p104, p205 단백질 절편 및 이의 용도 |
CN112444626B (zh) * | 2019-08-30 | 2023-09-12 | 洛阳普泰生物技术有限公司 | 一种非洲猪瘟病毒抗体elisa检测试剂盒及其制备方法 |
CN111018996A (zh) * | 2019-10-31 | 2020-04-17 | 河南省生物工程技术研究中心 | 一种非洲猪瘟中和表位亚单位疫苗 |
CN110760006B (zh) * | 2019-10-31 | 2023-09-29 | 河南省生物工程技术研究中心 | 一种非洲猪瘟免疫***靶向基因工程疫苗 |
CN111018995A (zh) * | 2019-10-31 | 2020-04-17 | 河南省生物工程技术研究中心 | 一种非洲猪瘟b、t细胞表位串联融合疫苗 |
CN111254103B (zh) * | 2019-11-19 | 2023-06-02 | 河南省生物工程技术研究中心 | 一种非洲猪瘟基因工程疫苗高密度发酵补料培养基及发酵工艺 |
CN110862435B (zh) * | 2019-12-05 | 2021-09-24 | 中国农业大学 | 非洲猪瘟ctl表位多肽及其应用 |
CN113388040B (zh) * | 2020-03-13 | 2022-08-09 | 普莱柯生物工程股份有限公司 | 非洲猪瘟病毒嵌合蛋白、疫苗组合物、制备方法及其应用 |
CN111363016A (zh) * | 2020-03-30 | 2020-07-03 | 中国农业大学 | 一种非洲猪瘟免疫抗原及其制备方法和应用 |
CN113150079B (zh) * | 2021-01-21 | 2021-12-31 | 中国检验检疫科学研究院 | 一种真核表达的非洲猪瘟病毒p72抗原及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102101889A (zh) * | 2009-12-16 | 2011-06-22 | 中国农业科学院饲料研究所 | 一种非洲猪瘟病毒vp73基因的原核表达蛋白及其制备方法 |
CN101818129B (zh) * | 2010-04-23 | 2011-11-02 | 天津出入境检验检疫局动植物与食品检测中心 | 一种分泌抗非洲猪瘟病毒单克隆抗体的杂交瘤细胞系及其所分泌的单克隆抗体 |
CN101831407B (zh) * | 2010-04-23 | 2012-06-06 | 天津出入境检验检疫局动植物与食品检测中心 | 抗非洲猪瘟病毒单克隆抗体的杂交瘤细胞系及其所分泌的单克隆抗体 |
-
2013
- 2013-02-01 CN CN201310038763.0A patent/CN103172749B/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021210924A1 (ko) * | 2020-04-14 | 2021-10-21 | (주)플럼라인생명과학 | 아프리카돼지열병 백신 조성물 |
Also Published As
Publication number | Publication date |
---|---|
CN103172749A (zh) | 2013-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103172749B (zh) | 一种非洲猪瘟蛋白工程疫苗的制备 | |
CN104248762B (zh) | 一种猪流行性腹泻疫苗组合物及其制备方法和应用 | |
CN102816246B (zh) | 一种人巨细胞病毒免疫原融合蛋白及其制备方法和用途 | |
CN104628865B (zh) | 一种伪狂犬表位多肽基因工程疫苗 | |
CN106279431B (zh) | 一种猪圆环病毒亚单位灭活疫苗 | |
CN104628871B (zh) | 一种重组法氏囊病蛋白工程疫苗的制备 | |
CN102210860B (zh) | 一种结核分枝杆菌tb10.4-f1融合蛋白疫苗及制备方法 | |
CN109021115A (zh) | 一种猪圆环病毒三价亚单位疫苗 | |
CN104894045B (zh) | 一种共表达***病毒vp1基因与免疫佐剂牛il-6基因的重组乳酸杆菌及其制备方法和应用 | |
CN102406929B (zh) | 一种共表达分子佐剂加强型二价***蛋白工程疫苗 | |
CN104804099B (zh) | 一种重组h9n2亚型禽流感加强型多表位疫苗 | |
CN104726413B (zh) | 一株牛支原体nadh氧化酶的单克隆抗体 | |
CN103992408A (zh) | 一种蓝耳病蛋白工程疫苗的制备 | |
CN109053896A (zh) | 一种猪圆环病毒二价基因工程疫苗 | |
CN102847168B (zh) | 一种预防奶牛乳腺炎的核酸疫苗PV-Fn的设计及其构建 | |
CN105622760A (zh) | 一种禽传染性支气管炎多表位粘膜免疫疫苗及其应用 | |
CN105535957A (zh) | 一种***o、a型双价灭活标记疫苗及其制备方法 | |
CN106397602B (zh) | 一种分子佐剂加强型鸡马立克氏病蛋白工程疫苗 | |
CN111138553B (zh) | 一种融合蛋白及一种弓形虫亚单位疫苗及其疫苗组合物 | |
CN107129527A (zh) | 一种马链球菌兽疫亚种保护性抗原hp0623及其制备方法 | |
CN109517044B (zh) | 一种猪流行性腹泻病毒基因工程抗原和抗体 | |
CN102372766B (zh) | 一种o型***多表位疫苗 | |
CN102212120A (zh) | 甲型副伤寒沙门氏菌PagC亚单位疫苗及其制备方法 | |
CN107827986B (zh) | 猪O/Mya98和O/PanAsia型***基因工程灭活疫苗 | |
CN101886084B (zh) | 一种密码子优化的h3ha/xj3-07基因及其核酸疫苗 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO HONGQIAO MINGQIN BIOTECHNOLOGY CO., LTD. Effective date: 20140819 Owner name: GUANGZHOU PUTAI BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: QINGDAO HONGQIAO MINGQIN BIOTECHNOLOGY CO., LTD. Effective date: 20140819 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266061 QINGDAO, SHANDONG PROVINCE TO: 510730 GUANGZHOU, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140819 Address after: 510730, 2020, building 35, West Garden Road, Guangzhou economic and Technological Development Zone, Guangdong, Guangzhou Applicant after: GUANGZHOU PUTAI BIOTECHNOLOGY Co.,Ltd. Applicant after: QINGDAO HONGQIAO MINGQIN BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 266061 Shandong City, Laoshan Province, Zhuzhou Road, No. 153, high-level personnel entrepreneurship center, building, room 1, unit B702 Applicant before: QINGDAO HONGQIAO MINGQIN BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510730, 2020, building 35, West Garden Road, Guangzhou economic and Technological Development Zone, Guangdong, Guangzhou Co-patentee after: QINGDAO MINGQIN BIOTECHNOLOGY CO.,LTD. Patentee after: GUANGZHOU PUTAI BIOTECHNOLOGY Co.,Ltd. Address before: 510730, 2020, building 35, West Garden Road, Guangzhou economic and Technological Development Zone, Guangdong, Guangzhou Co-patentee before: QINGDAO HONGQIAO MINGQIN BIOLOGICAL TECHNOLOGY Co.,Ltd. Patentee before: GUANGZHOU PUTAI BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180402 Address after: 266061 Shandong City, Laoshan Province, Zhuzhou Road, No. 153, high-level personnel entrepreneurship center, building, room 1, unit B302 Patentee after: QINGDAO MINGQIN BIOTECHNOLOGY CO.,LTD. Address before: 510730, 2020, building 35, West Garden Road, Guangzhou economic and Technological Development Zone, Guangdong, Guangzhou Co-patentee before: QINGDAO MINGQIN BIOTECHNOLOGY CO.,LTD. Patentee before: GUANGZHOU PUTAI BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |